was shown to be negative for the DNA of A. phagocytophilum when tested by a commercial service c using a published conventional PCR assay. 6 Ixodes scapularis (13 females, 12 males) collected in Rhode Island were placed on each cat under a tick chamber made of adhesive bandage materials for 7 days. d The prevalence rate of A. phagocytophilum DNA in a representative aliquot of adult female ticks (n = 30) from the capture area that year was shown to be approximately 15% using previously described methods. 10 While DNA of Ehrlichia canis, Ehrlichia ewingii, Ehrlichia chaffeensis, or Anaplasma platys were not amplified, approximately 50% of the ticks contained B. burgdorferi DNA. The cats were assessed for clinical signs of depression or inappetence daily. A temperature-sensing microchip was used to monitor body temperature daily. 11 Blood for a complete blood cell count, for A. phagocytophilum PCR assay, and to obtain serum for assessing B. burgdorferi and A. phagocytophilum antibodies was collected prior to placing I. scapularis on the cats, every week after tick infestation for 10 weeks, and then weekly from 13 to 18 weeks after tick infestation. Doxycycline was orally administered at 10 mg/kg daily for 14 days starting 13 weeks after tick infestation. Sera from each collection date was assayed for B. burgdorferi and A. phagocytophilum P44 antibodies using a commercially available kit and A. phagocytophilum P44-4 using an enzyme-linked immunosorbent assay (ELISA) titrated at the research laboratory but not available commercially. Western blot immunoassay was used to aid in optimizing the A. phagocytophilum P44-4 ELISA and to confirm that positive results for P44 and C6 in the commercial kit were true. 9 Multiple I. scapularis attached and had fed on each of the 4 cats by day 7. Clinical signs of illness were not recognized in any of the cats over the course of the study. When compared with the week 0 group mean, results for significant anemia, neutrophilia, thrombocytopenia, and monocytosis were not noted. Significant (P < 0.05) lymphopenia was detected on weeks 2 and 5 using a Student t-test (http:// graphpad.com/quickcalcs/contingency1.cfm).
Each cat had A. phagocytophilum DNA amplified from blood and 1 positive sample from each cat was shown to be most homologous with A. phagocytophilum by genetic sequencing (Fig. 1 ). Over the first 10 weeks of the study, A. phagocytophilum morulae were noted in neutrophils of all 4 cats at least once: week 3 (1 cat), week 5 (3 cats), and week 8 (1 cat), with an overall prevalence rate of 12.5% (5/40 samples). All of the morulae-positive samples also were positive for A. phagocytophilum DNA. During and after doxycycline administration, all samples were negative for A. phagocytophilum morulae and A. phagocytophilum DNA.
Each cat developed detectable A. phagocytophilum and B. burgdorferi antibodies in serum. However, in all 4 cats, DNA of A. phagocytophilum was amplified from blood prior to detecting A. phagocytophilum antibodies ( Table 1) . Antibodies against A. phagocytophilum P44-4 were detected 2-3 weeks prior to those detected by the commercially available kit in 3 out of 4 cats (Table 1) . Antibodies against A. phagocytophilum and B. burgdorferi persisted during and after doxycycline administration.
The results of our study document that cats can be infected with A. phagocytophilum and B. burgdorferi after being fed upon by infected I. scapularis. However, clinical abnormalities were not recognized in this small group of cats, and significant laboratory abnormalities were minimal, even though evidence of dual infection with A. phagocytophilum and B. burgdorferi existed. To our knowledge, evidence documenting B. burgdorferi-associated disease in cats has not been published, suggesting that the agent is not a primary pathogen in cats. 5 In contrast, several publications have suggested clinical disease associated with A. phagocytophilum infection in cats. 1, 2, 6 The failure of the cats in the current study to develop clinical anaplasmosis may have been related to the immune status of the cats (immunocompetent), the dose of the organism, or the strain of A. phagocytophilum. 4, 13 As with most rickettsial infections, A. phagocytophilum rickettsemia in cats can be detected by amplification of specific DNA from blood prior to detecting antibodies in serum. Thus, if a cat with clinical findings of anaplasmosis is seronegative for A. phagocytophilum antibodies, submission of blood for PCR amplification of Anaplasma spp. DNA is indicated. While all cats were negative for B. burgdorferi and A. phagocytophilum antibodies before I. scapularis infestation and then positive for antibodies against both organisms on multiple dates after tick infestation, further research will be needed to validate the use of this assay b with samples from cats, as the kit is not currently approved for this use. A cat with suspected anaplasmosis that is negative for A. phagocytophilum antibodies can have a second sample tested within 2-4 weeks to evaluate for seroconversion. Our study also suggests that the A. phagocytophilum P44-4 peptide might be a better target than the A. phagocytophilum P44 peptide when attempting to diagnose recent A. phagocytophilum infection in cats. In our study, the Anaplasma species infecting the cats was shown to be A. phagocytophilum by genetic sequencing. However, it has been shown that A. platys also can infect naturally exposed cats. 12 In dogs, antibodies against both A. phagocytophilum and A. platys bind to the A. phagocytophilum P44 peptide. e Further work will be needed to determine whether this also is true in cats. As for dogs, genetic sequencing or use of specific PCR assays should be used to determine whether the Anaplasma spp. causing infections in cats is A. phagocytophilum or A. platys.
Anaplasma phagocytophilum DNA was not amplified from blood during or after doxycycline administration to experimentally infected cats in our study. Most naturally infected cats become PCR negative after treatment as well. 6 There appear to be no reports of a cat with clinical anaplasmosis having recurrent clinical signs of disease or evidence of chronic illness following doxycycline treatment. However, it would be prudent to maintain tick control, as repeat infections could occur. In the experimentally exposed cats in our study, serum antibodies against A. phagocytophilum and B. burgdorferi persisted after the short course of doxycycline used. Further research will be required to determine whether there is clinical benefit to repeat serological testing of cats with A. phagocytophilum or B. burgdorferi infection. * Doxycycline was orally administered at 10 mg/kg daily for 14 days starting after blood was collected on week 13. A commercial kit a labeled for use with dog samples was used to detect AP P44 and BB antibodies in cat serum. The A. phagocytophilum polymerase chain reaction assay was performed using the standard operating procedures at Colorado State University. 6 
